Led by YSPH and partners at CIDEIM at Icesi University, the research team conducted the study in Cali, Colombia.

New tests recommended by the WHO can address TB cases with no or few symptoms more quickly and improve access to life-saving treatment.

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced newly published clinical and health economic data supporting the use of its QuantiFERON-TB Gold Plus (QFT-Plus) blood test for ...

Researchers at Tulane University in the US have created an improved clustered regularly interspaced short palindromic repeats (CRISPR)-based tuberculosis (TB) test that can be administered using a ...

In this episode we are joined by Hema Kapoor, MD, SM, D(ABMM), Senior Medical Director of Infectious Diseases/Immunology and Global Diagnostics Network, Medical Affairs at Quest Diagnostics, to ...

QIAGEN QGEN recently reached a major landmark in the field of tuberculosis (TB) testing. On World TB Day, the company announced that since the lime of its launch, the company’s QuantiFERON blood test ...

Please provide your email address to receive an email when new articles are posted on . Almost half of health care providers in the United States reported not routinely testing non-U.S.-born patients ...

The new government TB dashboard is a step forward for transparency and accountability in South Africa's response to the ...

is an experienced journalist with a diverse background in reporting, anchoring, and digital media. NUECES COUNTY, Texas — The Nueces County Health Department has made a significant change by halting ...